Osel Inc
  • ABOUT
  • OUR SCIENCE
  • WOMEN’S HEALTH
  • ONCOLOGY
  • PIPELINE
  • PUBLICATIONS
  • NEWS
  • CONTACT
  • COMMONLY ASKED QUESTIONS
Select Page

Inhibition of the cytotoxic effect of Clostridium difficile in vitro by Clostridium butyricum MIYAIRI 588 strain.

by Osel | Jan 23, 2011 | CBM588

Woo TD, Oka K, Takahashi M, Hojo F, Osaki T, Hanawa T, Kurata S, Yonezawa H, Kamiya S. J Med Microbiol. 2011 Nov;60(Pt 11):1617-25. doi: 10.1099/jmm.0.033423-0. Epub 2011 Jun 23.     Synopsis: This study investigated the inhibitory interaction between...

The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.

by Osel | Jul 1, 2004 | CBM588

Takahashi M, Taguchi H, Yamaguchi H, Osaki T, Komatsu A, Kamiya S. FEMS Immunol Med Microbiol. 2004 Jul 1;41(3):219-26.     Synopsis: Enterohemorrhagic Escherichia coli (EHEC) O157:H7 has been considered as an agent responsible for outbreaks of hemorrhagic...

Preventive efficacy of butyrate enemas and oral administration of Clostridium butyricum M588 in dextran sodium sulfate-induced colitis in rats.

by Osel | Feb 19, 2000 | CBM588

Okamoto T, Sasaki M, Tsujikawa T, Fujiyama Y, Bamba T, Kusunoki M. J Gastroenterol. 2000; 35(5):341-6.     Synopsis: Butyrate enemas have been reported to be effective in ulcerative colitis. However, long-term use is difficult because of the troublesome...
Next Entries »

Explore Publications

  • LACTIN-V
  • CBM588
  • MUCOCEPT